These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4549949)

  • 1. Anticonvulsant properties of delta 9-tetrahydrocannabinol and other cannabinoids.
    Karler R; Cely W; Turkanis SA
    Life Sci; 1974 Sep; 15(5):931-47. PubMed ID: 4549949
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol.
    Davis WM; Hatoum NS
    Gen Pharmacol; 1983; 14(2):247-52. PubMed ID: 6301931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice.
    Karler R; Turkanis SA
    Br J Pharmacol; 1980 Mar; 68(3):479-84. PubMed ID: 6301593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of 22-day treatment on the anticonvulsant properties of cannabinoids.
    Karler R; Borys HK; Turkanis SA
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Aug; 320(2):105-9. PubMed ID: 6289137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity.
    Martin BR; Kallman MJ; Kaempf GF; Harris LS; Dewey WL; Razdan RK
    Pharmacol Biochem Behav; 1984 Jul; 21(1):61-5. PubMed ID: 6087379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabichromene and delta 9-tetrahydrocannabinol: interactions relative to lethality, hypothermia and hexobarbital hypnosis.
    Hatoum NS; Davis WM; Elsohly MA; Turner CE
    Gen Pharmacol; 1981; 12(5):357-62. PubMed ID: 6269951
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of delta 9-tetrahydrocannabinol, cannabidiol, and shock on plasma corticosterone concentrations in rats.
    Jacobs JA; Dellarco AJ; Manfredi RA; Harclerode J
    J Pharm Pharmacol; 1979 May; 31(5):341-2. PubMed ID: 37310
    [No Abstract]   [Full Text] [Related]  

  • 8. Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat.
    Turkanis SA; Karler R
    Psychopharmacology (Berl); 1981; 75(3):294-8. PubMed ID: 6275447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Testing the pharmacological activity of some synthetic cannabinoids in mice (author's transl)].
    Ganz AJ; Waser PG
    Arzneimittelforschung; 1980; 30(3):471-7. PubMed ID: 7387758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of delta9-tetrahydrocannabinol and cannabidiol on photically evoked after-discharge potentials.
    Turkanis SA; Chiu P; Borys HK; Karler R
    Psychopharmacology (Berl); 1977 Apr; 52(2):207-12. PubMed ID: 407606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant activities of delta-8 and delta-9 tetrahydrocannabinol and uridine.
    Dwivedi C; Harbison RD
    Toxicol Appl Pharmacol; 1975 Mar; 31(3):452-8. PubMed ID: 1145630
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of brain [3H]flunitrazepam binding and analgesic activity of synthetic cannabimimetics.
    Koe BK; Milne GM; Weissman A; Johnson MR; Melvin LS
    Eur J Pharmacol; 1985 Feb; 109(2):201-12. PubMed ID: 2986995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the role of the phenolic hydroxyl in cannabinoid activity.
    Reggio PH; Seltzman HH; Compton DR; Prescott WR; Martin BR
    Mol Pharmacol; 1990 Dec; 38(6):854-62. PubMed ID: 2174506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
    Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
    J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.
    Hiltunen AJ; Järbe TU
    Eur J Pharmacol; 1986 Jun; 125(2):301-4. PubMed ID: 3017729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of delta9-tetrahydrocannabinol with phenobarbital, ethanol and chlordiazepoxide.
    Pryor GT; Larsen FF; Carr JD; Braude MC
    Pharmacol Biochem Behav; 1977 Oct; 7(4):331-45. PubMed ID: 928491
    [No Abstract]   [Full Text] [Related]  

  • 17. Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia.
    Smith PB; Martin BR
    Brain Res; 1992 Apr; 578(1-2):8-12. PubMed ID: 1324767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
    Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
    Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of delta9-tetrahydrocannabinol with other pharmacological agents.
    Consroe P; Jones B; Laird H
    Ann N Y Acad Sci; 1976; 281():198-211. PubMed ID: 798523
    [No Abstract]   [Full Text] [Related]  

  • 20. The cannabinoids as potential antiepileptics.
    Karler R; Turkanis SA
    J Clin Pharmacol; 1981; 21(S1):437S-448S. PubMed ID: 6975285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.